DAPAGLIFLOZIN

breakthrough for type-2 diabetes

FULL TECHNICAL AND REGULATORY SUPPORT

DAPAGLIFLOZIN (CAS 461432-26-8), also known as FORXIGA® and FARXIGA®, is a prescription medication used to control blood sugar levels in people with type-2 diabetes. Dapagliflozin works in the kidney to block a protein called SGLT2, which is in charge of delivering glucose into the bloodstream.

THERAPEUTIC INDICATION: ANTI-DIABETES

DAPAGLIFLOZIN is used for the treatment of type-2 diabetes. It is taken as film-coated tablets of 10mg.

MARKET INFORMATION

Originator: BRISTOL-MYERS SQUIBB in partnership with ASTRA ZENECA

Trade names: FORXIGA®, FARXIGA®

YOUR ADVANTAGES   

  • Reliable supply guaranteed
  • Short lead time with full technical and regulatory support

This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.